Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 20 04:00PM ET
14.04
Dollar change
+0.43
Percentage change
3.16
%
Index- P/E- EPS (ttm)-1.53 Insider Own17.60% Shs Outstand106.98M Perf Week-1.16%
Market Cap1.75B Forward P/E- EPS next Y-1.26 Insider Trans-0.12% Shs Float99.75M Perf Month5.41%
Income-182.55M PEG- EPS next Q-0.31 Inst Own78.78% Short Float6.92% Perf Quarter-36.79%
Sales629.74M P/S2.78 EPS this Y34.54% Inst Trans-0.95% Short Ratio3.30 Perf Half Y-29.38%
Book/sh5.97 P/B2.35 EPS next Y11.86% ROA-19.36% Short Interest6.90M Perf Year-74.26%
Cash/sh3.19 P/C4.40 EPS next 5Y- ROE-24.87% 52W Range12.95 - 57.90 Perf YTD-74.91%
Dividend Est.- P/FCF67.33 EPS past 5Y-13.04% ROI-22.84% 52W High-75.75% Beta1.83
Dividend TTM- Quick Ratio4.12 Sales past 5Y35.76% Gross Margin65.73% 52W Low8.42% ATR (14)0.98
Dividend Ex-Date- Current Ratio4.90 EPS Y/Y TTM20.22% Oper. Margin-28.30% RSI (14)42.35 Volatility7.91% 6.23%
Employees1259 Debt/Eq0.12 Sales Y/Y TTM6.56% Profit Margin-28.99% Recom2.30 Target Price20.20
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q62.51% Payout- Rel Volume0.97 Prev Close13.61
Sales Surprise-3.34% EPS Surprise8.70% Sales Q/Q-1.30% EarningsOct 29 AMC Avg Volume2.09M Price14.04
SMA20-7.54% SMA50-8.25% SMA200-37.03% Trades Volume2,024,544 Change3.16%
Date Action Analyst Rating Change Price Target Change
Sep-03-24Initiated Leerink Partners Outperform $35
Jul-22-24Upgrade Jefferies Hold → Buy $24
Jul-18-24Downgrade JP Morgan Overweight → Neutral $40 → $20
Jul-10-24Downgrade Deutsche Bank Buy → Hold $55 → $25
Jun-27-24Downgrade Wolfe Research Outperform → Peer Perform
Jun-25-24Downgrade Guggenheim Buy → Neutral
Jun-03-24Resumed Jefferies Hold $24
May-01-24Downgrade TD Cowen Buy → Hold $57 → $32
Dec-14-23Initiated Guggenheim Buy $60
Dec-13-23Initiated Wolfe Research Outperform $55
Nov-20-24 03:29PM
Nov-19-24 07:11PM
Nov-07-24 04:05PM
Oct-31-24 08:00AM
Oct-30-24 07:36AM
03:14AM Loading…
03:14AM
Oct-29-24 07:00PM
05:20PM
04:15PM
04:05PM
Oct-23-24 12:00PM
Oct-22-24 10:01AM
Oct-15-24 04:05PM
Oct-10-24 04:14PM
01:26PM
07:36AM Loading…
07:36AM
Oct-09-24 05:57PM
04:05PM
Oct-04-24 05:05PM
Oct-01-24 04:05PM
Sep-10-24 09:00AM
Sep-03-24 04:05PM
Aug-22-24 04:05PM
Aug-12-24 03:01PM
Aug-08-24 06:00PM
05:45PM
04:45PM
04:05PM
04:04PM
Aug-07-24 09:15AM
04:00PM Loading…
Aug-05-24 04:00PM
Aug-01-24 10:01AM
Jul-21-24 11:49PM
Jul-17-24 09:55AM
Jul-12-24 09:15AM
08:00AM
Jul-10-24 02:10PM
Jun-27-24 09:00AM
Jun-25-24 08:14AM
Jun-20-24 09:00AM
Jun-07-24 01:01PM
May-29-24 04:05PM
May-10-24 07:01AM
May-07-24 02:45PM
May-06-24 01:04PM
09:08AM
May-02-24 04:05PM
06:04AM
May-01-24 12:59PM
11:33AM
11:05AM
03:27AM
01:01AM
Apr-30-24 08:57PM
06:30PM
05:43PM
04:38PM
04:05PM
Apr-29-24 11:01AM
Apr-25-24 11:28AM
Apr-24-24 09:35AM
Apr-23-24 10:01AM
Apr-22-24 12:00PM
Apr-18-24 06:46AM
Apr-10-24 04:05PM
Mar-26-24 09:00AM
Mar-21-24 04:05PM
Mar-13-24 04:05PM
08:17AM
Mar-01-24 02:00PM
Feb-27-24 11:55AM
Feb-20-24 04:05PM
Feb-16-24 10:21AM
08:14AM
Feb-15-24 06:00PM
05:20PM
04:40PM
04:17PM
04:05PM
Feb-08-24 10:00AM
Feb-07-24 04:05PM
Feb-05-24 04:05PM
11:18AM
Jan-30-24 01:03PM
Jan-24-24 04:05PM
Jan-08-24 09:00AM
Dec-21-23 04:05PM
Dec-20-23 04:05PM
Dec-19-23 09:00AM
Dec-13-23 04:26PM
Dec-10-23 11:59AM
Dec-07-23 09:00AM
Nov-23-23 11:05AM
Nov-19-23 09:08AM
Nov-17-23 05:22PM
Nov-09-23 01:12AM
Nov-06-23 04:05PM
Nov-03-23 11:09AM
09:14AM
Nov-02-23 07:43PM
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saxonov SergeChief Executive OfficerNov 22 '24Sale13.696,69391,612872,574Nov 25 04:53 PM
Hindson Benjamin J.See RemarksNov 22 '24Sale13.695,80779,485339,897Nov 25 04:52 PM
Hindson Benjamin J.OfficerNov 22 '24Proposed Sale13.325,73476,377Nov 22 04:56 PM
Saxonov SergeOfficerNov 22 '24Proposed Sale13.326,60888,019Nov 22 04:38 PM
Saxonov SergeChief Executive OfficerAug 22 '24Sale22.536,749152,053882,467Aug 26 05:05 PM
Hindson Benjamin J.See RemarksAug 22 '24Sale22.534,35198,027345,704Aug 26 05:04 PM
McAnear Justin J.Former Chief Financial OfficerAug 22 '24Sale22.532,96166,710143,242Aug 26 05:03 PM
Saxonov SergeOfficerAug 22 '24Proposed Sale23.016,749155,294Aug 22 08:45 PM
McAnear Justin J.OfficerAug 22 '24Proposed Sale23.012,96168,133Aug 22 08:42 PM
Hindson Benjamin J.OfficerAug 22 '24Proposed Sale23.014,351100,117Aug 22 08:39 PM
McAnear Justin J.Chief Financial OfficerMay 22 '24Sale24.302,93671,355146,203May 23 07:54 PM
Saxonov SergeChief Executive OfficerMay 22 '24Sale24.304,877118,529889,641May 23 07:53 PM
Hindson Benjamin J.See RemarksMay 22 '24Sale24.304,08799,329350,055May 23 07:52 PM
Saxonov SergeChief Executive OfficerMar 04 '24Sale44.004,660205,021842,900Mar 06 04:12 PM
Saxonov SergeChief Executive OfficerFeb 22 '24Sale46.342,821130,737847,560Feb 26 04:13 PM
Hindson Benjamin J.See RemarksFeb 22 '24Sale46.342,613121,098283,059Feb 26 04:12 PM
McAnear Justin J.Chief Financial OfficerFeb 22 '24Sale46.341,86586,43295,240Feb 26 04:12 PM
Saxonov SergeChief Executive OfficerFeb 15 '24Sale48.875,000244,332850,381Feb 20 04:20 PM
Saxonov SergeChief Executive OfficerFeb 09 '24Sale49.531,00049,530855,381Feb 13 04:56 PM
Saxonov SergeChief Executive OfficerJan 16 '24Sale45.244,000180,956856,381Jan 18 04:49 PM
Hindson Benjamin J.See RemarksDec 28 '23Option Exercise11.488,33495,674285,672Dec 29 04:19 PM
Saxonov SergeChief Executive OfficerDec 27 '23Option Exercise1.2014,93517,922860,381Dec 29 04:17 PM